Icon PLC: Q3 Earnings Snapshot

Icon PLC reported Q3 net income of $122.1M, or $1.58 per share, and adjusted earnings of $2.66 per share, exceeding analyst expectations of $2.64 per share. Revenue was $2.02B. The company forecasted full-year earnings of $10.35-$10.65 per share and revenue of $8.1B-$8.2B.

Original reporting
Published Oct 28, 2026, 6:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 6:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Icon PLC: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$ICLRBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest stronger demand for CRO services, potentially boosting related stocks.

02

Market read

Fresh earnings data provides a clear trading signal for ICLR and peers in the CRO sector.

03

What to watch

Currency fluctuations and potential client contract renewals could affect future performance.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Icon PLC is a Dublin‑based contract research organization serving pharma and biotech clients.

Company-level read

Ticker impact

$ICLRBullishHigh confidence
Context

Icon PLC reported Q3 net income of $122.1M, EPS $2.66 beating estimates and raised FY guidance to $10.35‑$10.65 per share.

Expected impact

potential upside as market prices in the earnings beat and raised guidance

Evidence & confidence

The surprise earnings beat and upgraded guidance provide a fresh catalyst for buying pressure.

Market effects

Strong results may lift other contract research organizations and biotech service providers.

Positive for Irish and European biotech service sector.

Adds confidence to the broader CRO industry amid rising R&D spending.

Counterpoint

If guidance falls short of market expectations later, the rally could reverse.

Key entities

  • Icon PLC

    Contract research organization reporting Q3 results.

Related articles

$ICLRMed

Icon PLC (ICLR) (Q3 2026) Earnings Call Highlights: Record

Icon PLC (ICLR) reported Q3 2026 revenue of $2B, down 2.9% YoY. Direct fee revenue growth remains modest, and cancellations are slightly above average. Gross margin improved 90 bps sequentially, and adjusted EBITDA margin rose to 16.6%. The company expects Q4 SG&A expenses to increase and faces ongoing pricing pressure. Management anticipates mid-single-digit revenue growth and higher single-digit earnings growth in 2027, with formal guidance to be provided in Q4.

$ICLRHighAI 8/10

ICLR Stock Jumps As Guidance And Backlog Impress Wall Street

ICON plc (NASDAQ: ICLR) stock rose 16.39% on October 28, 2026, after beating Q3 earnings expectations and raising 2026 revenue guidance to $8.10B–$8.20B. The company reported adjusted EPS of $2.66 and revenue of $2.02B, with a record backlog and $400M in share repurchases. Analysts have mixed reactions, with upgrades from Bank of America and RBC, while UBS remains cautious.

$ICLRHighAI 8/10

ICLR Stock Jumps As Earnings Beat And Guidance Rise

ICON plc (ICLR) stock rose 11.54% after Q3 earnings beat expectations, with revenue of $2.02B and EPS of $2.66. The company raised full-year guidance, citing strong demand and a record backlog. Analysts have mixed views, with some upgrading and others warning of risks. ICLR trades at a premium multiple, with technical indicators showing strong momentum.